Waiving all fees associated with colorectal cancer screening, even charges related to removal of polyps, saves money without sacrificing the quality of care, Dutch researchers have found.
The study, which used a virtual population simulation model that projected risks and costs, found that waiving copayments costs less than $50,000 per quality-adjusted life-year (QALY)—the threshold commonly used as an upper limit for defining cost-effective interventions. Assuming the elimination of any